Back

Hyper-Kalaemia as cause for discontinuation of RAASi in patients with heart failure

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Drug therapy, other Drug therapy, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Giuseppe Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Laboratory aspirin resistance reversibility in coronary artery disease and chronic obstructive pulmonary disease patients after coronary stent implantation
Professor I. Pershukov (Osh, KG)
Abstract Slides
Presentation thumbnail
Temporal trends in the use of digoxin in patients heart failure
Presentation thumbnail
P2Y12 inhibitors in acute coronary syndrome: relation to hemorrhagic events in routine clinical practice
Doctor A. Godinho (Braganca, PT)
Abstract
Presentation thumbnail
Analysis of changes of ECHO-cardiogram indices in patients with chronic heart failure during therapy with coenzyme Q10
Professor G. KUKHARCHIK (Kotka, FI)
Abstract
Presentation thumbnail
Prognostic impact of polypharmacy drugs across heart failure phenotypes: an unmet need.
Doctor C. Di Nora (Udine, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Drug therapy, other

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources